0001354457-23-000492.txt : 20230710
0001354457-23-000492.hdr.sgml : 20230710
20230710060805
ACCESSION NUMBER: 0001354457-23-000492
CONFORMED SUBMISSION TYPE: 25-NSE
CONFIRMING COPY:
PUBLIC DOCUMENT COUNT: 2
FILED AS OF DATE: 20230710
DATE AS OF CHANGE: 20230710
SUBJECT COMPANY:
COMPANY DATA:
COMPANY CONFORMED NAME: ONCOSEC MEDICAL Inc
CENTRAL INDEX KEY: 0001444307
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 980573252
STATE OF INCORPORATION: NV
FISCAL YEAR END: 0731
FILING VALUES:
FORM TYPE: 25-NSE
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-54318
BUSINESS ADDRESS:
STREET 1: 820 BEAR TAVERN ROAD
CITY: EWING
STATE: NJ
ZIP: 08628
BUSINESS PHONE: (858) 210-7333
MAIL ADDRESS:
STREET 1: 820 BEAR TAVERN ROAD
CITY: EWING
STATE: NJ
ZIP: 08628
FORMER COMPANY:
FORMER CONFORMED NAME: NetVentory Solutions, Inc.
DATE OF NAME CHANGE: 20080902
FILED BY:
COMPANY DATA:
COMPANY CONFORMED NAME: Nasdaq Stock Market LLC
CENTRAL INDEX KEY: 0001354457
IRS NUMBER: 521165937
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 25-NSE
BUSINESS ADDRESS:
STREET 1: One Liberty Plaza
CITY: New York
STATE: NY
ZIP: 10006
BUSINESS PHONE: 301-978-4144
MAIL ADDRESS:
STREET 1: Office of General Counsel
STREET 2: 805 King Farm Blvd.
CITY: ROCKVILLE
STATE: MD
ZIP: 20850
FORMER COMPANY:
FORMER CONFORMED NAME: The Nasdaq Stock Market LLC
DATE OF NAME CHANGE: 20060224
25-NSE
1
primary_doc.xml
X0203
0001354457
Nasdaq Stock Market LLC
0001444307
ONCOSEC MEDICAL Inc
000-54318
9810 Summers Ridge Road, Suite 110
San Diego
CA
CALIFORNIA
92121
858-210-7332
Common Stock
17 CFR 240.12d2-2(b)
Aravind Menon
Hearings Advisor
2023-07-10
EX-99.25
2
oncsdelistreason.txt
Delisting Determination, The Nasdaq Stock Market, LLC, July 10, 2023,
OncoSec Medical Incorporated.
The Nasdaq Stock Market LLC (the Exchange) has determined to remove
from listing the common stock of OncoSec Medical Incorporated,
effective at the opening of the trading session on July 20, 2023.
Based on review of information provided by the Company, Nasdaq
Staff determined that the Company no longer qualified for listing
on the Exchange pursuant to Listing Rules 5101, 5110(b), and
IM-5101-1. The Company was notified of the Staff determination on
June 15, 2023. The Company did not appeal the Staff determination
to the Hearings Panel. The Company securities were suspended on
June 26, 2023. The Staff determination to delist the Company
securities became final on June 26, 2023.